Buyback Spend for Amgen (AMGN)
Buyback Spend for Amgen (AMGN): headline value $0 · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingBuyback SpendSwitch metric
Latest period
$0
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2018)
$17.79B
Latest annual
$0
Buyback Spend history chart for Amgen (AMGN) from 1988 to 2025
Buyback Spend history table for Amgen (AMGN) from 1988 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $0 | -100.0% | ||
| 2024 | $200.00M | — | ||
| 2023 | $0 | -100.0% | ||
| 2022 | $6.36B | +27.8% | ||
| 2021 | $4.97B | +42.7% | ||
| 2020 | $3.49B | -54.7% | ||
| 2019 | $7.70B | -56.7% | ||
| 2018 | $17.79B | +463.1% | ||
| 2017 | $3.16B | +6.6% | ||
| 2016 | $2.96B | +58.8% | ||
| 2015 | $1.87B | +1252.9% | ||
| 2014 | $138.00M | -83.4% | ||
| 2013 | $832.00M | -81.9% | ||
| 2012 | $4.61B | -44.6% | ||
| 2011 | $8.31B | +119.6% | ||
| 2010 | $3.79B | +18.0% | ||
| 2009 | $3.21B | +41.4% | ||
| 2008 | $2.27B | -55.5% | ||
| 2007 | $5.10B | +155.0% | ||
| 2006 | $2.00B | -54.9% | ||
| 2005 | $4.43B | +8.8% | ||
| 2004 | $4.07B | +126.1% | ||
| 2003 | $1.80B | +26.8% | ||
| 2002 | $1.42B | +92.5% | ||
| 2001 | $737.50M | -7.8% | ||
| 2000 | $799.90M | -21.9% | ||
| 1999 | $1.02B | +12.3% | ||
| 1998 | $912.10M | +23.6% | ||
| 1997 | $737.90M | +64.0% | ||
| 1996 | $450.00M | +57.5% | ||
| 1995 | $285.70M | -4.9% | ||
| 1994 | $300.50M | +44.8% | ||
| 1993 | $207.50M | +141.6% | ||
| 1992 | $85.90M | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — | ||
| 1988 | $0 | — |
Buyback Spend values are taken from Amgen's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Amgen (AMGN) most recent annual buyback spend stands at $0 (2025) – plunged 100.0% year-over-year.
Amgen buyback spend has contracted on net over the period, with a -100.0% compound annual growth rate over 2020–2025 (5 years).
Amgen buyback spend plunged from $17.79B in 2018 to $0 in 2025, a 100.0% drawdown.
$17.79B stands as the all-time-high annual buyback spend, posted in 2018, against a low of $0 during 1988.
Amgen (AMGN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.55B.
Amgen Buyback Spend by Year
Amgen Buyback Spend 2025: $0
Amgen buyback spend in 2025 was $0, plunged 100.0% below 2024.
Amgen Buyback Spend 2024: $200.00M
Amgen buyback spend in 2024 was $200.00M.
Amgen Buyback Spend 2023: $0
Amgen buyback spend in 2023 was $0, plunged 100.0% below 2022.
Amgen Buyback Spend 2022: $6.36B
Amgen buyback spend in 2022 was $6.36B, grew 27.8% from 2021.
Amgen Buyback Spend 2021: $4.97B
Amgen buyback spend in 2021 was $4.97B.
See more financial history for Amgen (AMGN).
Sector peers — Buyback Spend
Companies in the same sector as Amgen, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $3.00B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
Frequently asked questions
What is Amgen's buyback spend?
Latest reported buyback spend for Amgen (AMGN) is $0 (period ending December 31, 2025).
How has Amgen buyback spend changed year-over-year?
Amgen (AMGN) buyback spend changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen buyback spend?
Amgen (AMGN) buyback spend compound annual growth rate is -100.0% over the most recent 5 years available.
When did Amgen buyback spend hit its highest annual value?
Amgen buyback spend reached its highest annual value of $17.79B in 2018.
What was Amgen buyback spend in 2024?
Amgen (AMGN) buyback spend in 2024 was $200.00M.
What was Amgen buyback spend in 2025?
Amgen (AMGN) buyback spend in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.